The connection between IFN-α and human mental disorders was first identified in patients who frequently exhibited neurotoxicity and neuropsychiatric side effects such as anxiety, depression, irritability, a lack of motivation and impaired memory after receiving a high dose of IFN-α [11, 12]. Here, IFNA1 is linked to depressive disorder.